CorePharma's Generic Chlordiazepoxide HCL;Clidinium bromide Receives Approval in the U.S.
Bi-Coastal Pharma International Receives FDA Warning Letter
Micro Labs Generic Chlordiazepoxide Hydrochloride Receives Approval in the U.S.
Amneal ’s Generics Chlordiazepoxide;Clidinium bromide Receives Approvals In US
Dr. Reddy's Laboratories Ltd announced the launch of chlordiazepoxide hydrochloride and clidinium bromide capsules USP, 5 mg/2.5 mg, a therapeutic equivalent generic version of Librax (chlordiazepoxide hydrochloride and clidinium bromide) approved by the US Food and Drug Administration (FDA).
ECI Pharm`s Generic Chlordiazepoxide; Clidinium bromide Receives Approval in US
Misemer`s Generic Chlordiazepoxide HCL Phosphate Receives Approval in US
Sunrise Generic Chlordiazepoxide HCL; Clidinium bromide Receives Approval In US
MORRISVILLE, N.C.--(BUSINESS WIRE)-- Circassia Pharmaceuticals Inc. (“Circassia” or “the Company”), today announced the launch of DUAKLIR® PRESSAIR® (aclidinium bromide and formoterol fumarate) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).1 DUAKLIR will be available in the United States on October 21st and promoted through its dedicated COPD sales force, alongside established COPD treatment TUDORZA® (aclidinium), which is also administered twice-daily via PRESSAIR®. The US launch of DUAKLIR will happen simultaneously with the American College of Chest Physicians’ CHEST Annual Meeting 2019 in New Orleans, LA.